References
Clark PM, Hales CN. How to measure plasma insulin. Diabetes Metab Rev. 1994;10(2):79–90.
Ido Y, Vindigni A, Chang K, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science (New York, NY). 1997;277(5325):563–6.
Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia. 1992;35(2):121–8.
Irwin ML, Duggan C, Wang CY, et al. Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(1):47–53.
Chen CH, Tsai ST, Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance. Int J Cardiol. 1999;68(2):179–86.
Bergstrom RW, Newell-Morris LL, Leonetti DL, et al. Association of elevated fasting C-peptide and increased intraabdominal fat distribution with development of NIDDM in Japanese American men. Diabetes. 1990;39(1):104–11.
Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B. Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais. J Clin Lab Anal. 2007;21(2):85–90.
Chen CH, Tsai ST, Chuang JH, Chang MS, Wang SP, Chou P. Population-based study of insulin, C-peptide, and blood pressure in Chinese with normal glucose tolerance. Am J Cardiol. 1995;76(8):585–8.
Efrat S. Prospects for treatment of type 2 diabetes by expansion of the beta-cell mass. Diabetes. 2001;50(Suppl 1):S189–90.
Porte D Jr. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. Diabetes/Metab Res Rev. 2001;17(3):181–8.
Acknowledgments
We thank members of the National Center for Health Statistics (NCHS) of the Centers for Disease Control (CDC) and Prevention and the participants who enrolled in the study. This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant Number, 2012R1A1A3017058).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Min, JY., Min, KB. Serum C-peptide levels as an independent predictor of diabetes mellitus mortality in non-diabetic individuals. Eur J Epidemiol 28, 771–774 (2013). https://doi.org/10.1007/s10654-013-9836-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-013-9836-5